Clinical significance and diagnostic usefulness of serologic markers for improvement of outcome of tonsillectomy in adults with chronic tonsillitis

Table 3 Results of the Glasgow Benefit Inventory (GBI) and of the Specific Benefits from Tonsillectomy Inventory (SBTI)

Score	Chronic tonsillitis		Peritonsillar abscess		p**
Score	Mean	SD*	Mean	SD*	p**
GBI total score (T180)	24.2	20.9	7.8	15.5	0.013
GBI subscores (T180)
General health	25.6	21.4	7.0	17.0	0.009
Social support	6.7	20.5	2.1	5.7	0.965
Physical functioning	45.2	42.2	16.7	32.2	0.013
SBTI (T-1)
Total score	-3.0	37.0	52.7	39.0	<0.0001
Symptom score	-0.8	32.7	47.0	44.7	<0.0001
Resources	-5.3	46.7	68.3	37.4	<0.0001
SBTI (T180)
Total score	68.8	41.3	67.9	34.3	0.571
Symptom score	66.7	40.8	62.2	33.0	0.412
Resources	72.5	43.7	76.2	39.1	0.891
Benefit	61.9	32.2	40.6	31.5	0.059
SBTI (ΔT***)
Total score	74.12	68.77	22.44	57.47	0.030
Symptom score	67.50	63.63	20.24	58.90	0.049
Resources	81.58	76.95	23.08	59.14	0.024
Absolute number of patients with changes of SBTI score between T-1 and T180 (ΔT***)	N****		N****		p**
Total score					0.132
Improved	15		7
Unchanged/deteriorated	4		6
Symptom score					0.150
Improved	16		8
Unchanged/deteriorated	4		6
Resources					0.146
Improved	16		8
Unchanged/deteriorated	3		5

*SD standard deviation; **p p value due to Mann–Whitney U test; significant p values (<0.05) in bold; ***the scores at T108 were subtracted from the values at T-1; ****the sample size N could be smaller than 24 as not all patients answered the SBTI T180 or answered all questions.

ISSN: 1477-5751